eHealth Secures $150M Credit Facility
Ticker: EHTH · Form: 8-K · Filed: Nov 1, 2024 · CIK: 1333493
| Field | Detail |
|---|---|
| Company | Ehealth, Inc. (EHTH) |
| Form Type | 8-K |
| Filed Date | Nov 1, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $70.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: debt, financing, credit-facility
Related Tickers: EHTH
TL;DR
eHealth just landed a $150M credit line, maturing in 2029, with room to borrow another $50M.
AI Summary
On November 1, 2024, eHealth, Inc. entered into a material definitive agreement, specifically a credit agreement with an initial aggregate principal amount of $150 million. This agreement also includes an accordion feature allowing for an additional $50 million, bringing the potential total to $200 million. The credit agreement matures on November 1, 2029.
Why It Matters
This new credit facility provides eHealth with significant financial flexibility and access to capital, which could be used for strategic initiatives, acquisitions, or general corporate purposes.
Risk Assessment
Risk Level: medium — The company is taking on new debt, which increases its financial leverage and introduces interest payment obligations.
Key Numbers
- $150.0M — Credit Facility Amount (Initial principal amount secured by eHealth, Inc.)
- $200.0M — Potential Total Borrowing (Includes the accordion feature for additional funds.)
- 5 years — Maturity Term (The credit agreement is set to mature on November 1, 2029.)
Key Players & Entities
- eHealth, Inc. (company) — Registrant
- $150 million (dollar_amount) — Initial aggregate principal amount of credit agreement
- $50 million (dollar_amount) — Accordion feature for additional borrowing
- November 1, 2029 (date) — Maturity date of the credit agreement
- November 1, 2024 (date) — Date of the earliest event reported
FAQ
What is the purpose of the new credit agreement?
The filing states the credit agreement is a material definitive agreement, and while specific uses aren't detailed, such agreements typically provide capital for general corporate purposes, strategic initiatives, or acquisitions.
What are the terms of the credit agreement?
The credit agreement has an initial aggregate principal amount of $150 million, with an accordion feature allowing for an additional $50 million, and matures on November 1, 2029.
Who is the lender for this credit facility?
The filing does not explicitly name the lender in the provided text, only that eHealth, Inc. entered into a credit agreement.
What is the total potential borrowing capacity under this agreement?
The total potential borrowing capacity is $200 million, consisting of the initial $150 million principal amount plus an additional $50 million available through the accordion feature.
When does the credit agreement expire?
The credit agreement matures on November 1, 2029.
Filing Stats: 734 words · 3 min read · ~2 pages · Grade level 10.1 · Accepted 2024-11-01 16:26:58
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share EHTH The Nasdaq Stock Market
- $70.0 million — fee in an amount equal to 1.50% of the $70.0 million aggregate principal amount of loans out
Filing Documents
- ehth-20241101.htm (8-K) — 29KB
- exhibit101.htm (EX-10.1) — 1143KB
- 0001333493-24-000165.txt ( ) — 1486KB
- ehth-20241101.xsd (EX-101.SCH) — 2KB
- ehth-20241101_lab.xml (EX-101.LAB) — 21KB
- ehth-20241101_pre.xml (EX-101.PRE) — 12KB
- ehth-20241101_htm.xml (XML) — 3KB
01 Entry into a Material Definitive Agreement
Item 1.01 Entry into a Material Definitive Agreement. On November 1, 2024, eHealth, Inc. (the "Company") entered into that certain Second Amendment to Credit Agreement ("Amendment No. 2"), which amends that certain Credit Agreement, dated as of February 28, 2022, by and among the Company, as Borrower, Blue Torch Finance LLC, as administrative agent and collateral agent for the lenders, and each lender party thereto (as amended, restated, amended and restated, supplemented and/or otherwise modified prior to Amendment No. 2, the "Original Credit Agreement" and, as amended by Amendment No. 2, the "Credit Agreement"). Amendment No. 2 amends the Original Credit Agreement to, among other things, (i) extend the maturity date of the Original Credit Agreement from February 28, 2025 to February 27, 2026, (ii) remove the "exit fee" contemplated by the Original Credit Agreement and replace it with an "applicable premium" that is payable in the event of any voluntary prepayment or certain mandatory prepayments of the loans under the Credit Agreement in an amount equal to 1.00% of the loans being prepaid, plus , solely in the case of loans prepaid on or prior to March 1, 2025, an additional "make-whole" amount, and (iii) reduce the margin applicable to SOFR loans from 7.50% to 7.00% and the margin applicable to base rate loans from 6.50% to 6.00%. Pursuant to Amendment No. 2, the Company paid to the lenders under the Original Credit Agreement an extension fee in an amount equal to 1.50% of the $70.0 million aggregate principal amount of loans outstanding thereunder. The foregoing description of Amendment No. 2 does not purport to be complete and is qualified in its entirety by reference to the full text of Amendment No. 2 a copy of which is attached hereto as Exhibit 10.1. Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 of this Current Report on Form 8-K i
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Second Amendment to Credit Agreement, dated November 1, 2024 , by and among eHealth, Inc., Blue Torch Finance LLC and the other lenders identified therein . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. eHealth, Inc. Date: November 1, 2024 /s/ John Dolan John Dolan Chief Financial Officer (Principal Financial Officer)